Related Experiment Video
Updated: Jan 15, 2026

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
Published on: October 23, 2018
Aerosolization of Mycobacterium chelonae from heater-cooler-devices: a continuing risk of exposure during cardiac
Sabine Kuster1, Pascal Urwyler1, Gioele Capoferri1
1Division of Infectious Diseases, University Hospital Basel, Petersgraben 4, CH-4031, Basel, Switzerland.
Background:
Following identification of widespread Mycobacterium chimaera infections in 2013 associated with aerosolization from Sorin heater-cooler-devices (HCD), microbiological monitoring of HCDs has become mandatory in Switzerland.
Methods:
Since 01/2016, four Maquet HCU40 (Getinge) HCDs have been in operation at the University Hospital Basel. Monthly water cultures for Gram-negative bacteria and mycobacteria were performed, including samples from two filling lines equipped with 0.2 μm water filters. Intermittent monthly air sampling for mycobacteria was conducted.
Results:
Between 01/2016 and 05/2018, various non-fermenting bacteria were cultured. Mycobacterium chelonae was first isolated in 06/2018 from HCD water tanks. Mycobacteria cultures from the filling lines remained negative. The first air sample positive for M. chelonae was collected in 12/2019. Despite intensified disinfection measures from 01/2022 onwards, M. chelonae could be cultured in air samples, collected at 30 cm and 120 cm height adjacent to three of the four running HCDs in 07/2022. Whole genome sequencing identified a cluster of isolates differing by a maximum of four single nucleotide polymorphisms. Despite extensive investigations, the source of M. chelonae remains undetermined. To date, no infections with M. chelonae have been related to the contaminated HCDs at our institution.
Conclusions:
Our data confirms the risk of aerosolization of non-tuberculous mycobacteria from HCDs, irrespective of HCD-design and manufacturer. These findings underscore the importance of routine microbiological surveillance, including both water and air sampling when HCDs are placed within the operation room to prevent exposure of the operating field to the air exhausts of HCDs.
Related Concept Videos
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

